Regulatory and Clinical Automation DDi offers a comprehensive suite of Regulatory and Clinical solutions including Regulatory Intelligence, Automaton, RIM, eIFU management, E2E Labeling, and RBM. This presents a cross-sell opportunity to mid-size pharma and CROs seeking end-to-end automation and compliance efficiency.

Enterprise Scale Fit With 201-500 employees and a focus on enterprise-grade automation for regulatory, clinical, and safety domains, DDi is well positioned to expand within mid-market to enterprise life sciences customers seeking scalable, low-friction deployment and strong support.

Technology Stack Leverage DDi’s technology footprint including web optimization and security tools (OpenSSL, Apache, CDN assets) suggests capability to bolster customers with robust, secure, and fast regulatory and clinical portals, enabling upsell of performance and compliance enhancements.

Industry Trends Alignment Market emphasis on AI-enabled regulatory operations and automated submissions aligns with DDi’s automation offerings. Prospects in regulated industries seeking faster time-to-market and reduced manual writing can be targeted for modernization projects.

Strategic Partnerships Recent news activity around AI and advertising strategies indicates potential for collaboration on data-driven regulatory intelligence or clinical trial optimization, enabling joint go-to-market with CROs, biotech startups, or larger pharma clients pursuing innovative tech-enabled compliance.